HOB BIOTECH GROUP CORP.,LTD. — Investor Relations & Filings
About HOB BIOTECH GROUP CORP.,LTD.
HOB Biotech Group Corp., Ltd. specializes in the development, manufacture, and distribution of in vitro diagnostic (IVD) products, with a primary focus on allergy and autoimmune disease testing. The company provides a comprehensive range of diagnostic solutions, including enzyme-linked immunosorbent assays (ELISA), line immunoassays, and advanced chemiluminescence immunoassay (CLIA) systems. Its product portfolio covers hundreds of allergens and a wide array of autoimmune markers, catering to clinical laboratories and healthcare providers. HOB Biotech is recognized for its proprietary technology platforms that enable high-throughput, automated testing, improving diagnostic efficiency and accuracy. The company's commitment to research and development supports the continuous expansion of its diagnostic menu to address evolving clinical needs in immunology and hypersensitivity.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 江苏浩欧博生物医药股份有限公司2026年第一次临时股东会会议资料 | 2026-04-30 | Chinese | |
| 江苏浩欧博生物医药股份有限公司关于召开2026年第一次临时股东会的通知 | 2026-04-27 | Chinese | |
| 江苏浩欧博生物医药股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-27 | Chinese | |
| 江苏浩欧博生物医药股份有限公司关于召开2025年年度暨2026年第一季度业绩说明会的公告 | 2026-04-27 | Chinese | |
| 江苏浩欧博生物医药股份有限公司2026年第一季度报告 | 2026-04-27 | Chinese | |
| 国浩律师（上海）事务所关于江苏浩欧博生物医药股份有限公司2023年限制性股票激励计划首次授予部分第一类激励对象第一个归属期归属条件成就及部分限制性股票作废相关事项之法律意见书 | 2026-04-09 | Chinese |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
HOB BIOTECH GROUP CORP.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58562/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58562 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58562 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58562 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58562}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HOB BIOTECH GROUP CORP.,LTD. (id: 58562)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.